Search Result "CHF5022"
Non-Cholinergic Pharmacotherapy Approaches to Alzheimers Disease: The Use of Non-Steroidal Anti-Inflammatory Drugs
Journal: CNS & Neurological Disorders - Drug Targets
Volume: 10 Issue: 1 Year: 2011 Page: 133-139
Author(s): S. Tsartsalis, P. K. Panagopoulos, M. Mironidou-Tzouveleki
From the Multifactorial Nature of Alzheimer`s Disease to Multitarget Therapy: The Contribution of the Translational Approach
Journal: Current Topics in Medicinal Chemistry
Volume: 13 Issue: 1 Year: 2013 Page: 1843-1852
Author(s):
CHF5074 Protects SH-SY5Y Human Neuronal-like Cells from Amyloidbeta 25-35 and Tumor Necrosis Factor Related Apoptosis Inducing Ligand Toxicity In Vitro
Journal: Current Alzheimer Research
Volume: 11 Issue: 7 Year: 2014 Page: 714-724
Author(s): Nicole Ronsisvalle, Giulia Di Benedetto, Carmela Parenti, Salvatore Amoroso, Renato Bernardini, Giuseppina Cantarella
APP Transgenic Mouse Models and their Use in Drug Discovery to Evaluate Amyloid-β Lowering Therapeutics
Journal: CNS & Neurological Disorders - Drug Targets
Volume: 9 Issue: 4 Year: 2010 Page: 395-402
Author(s): Ishrut Hussain
γ-Secretase Substrates and their Implications for Drug Development in Alzheimers Disease
Journal: Current Topics in Medicinal Chemistry
Volume: 11 Issue: 1 Year: 2011 Page: 1513-1527
Author(s): Alberto Lleo, Carlos A. Saura